Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

REMOVED: Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine

Progress in brain research(2020)10.1016/bs.pbr.2020.09.004Source: DataRank Database

REMOVED: Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine is a research paper published in Progress in brain research (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

8 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.14)OA: closedTopics (38)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Aruna Sharma ORCID,Seaab Sahib,Z. Ryan Tian ORCID,Lianyuan Feng,Ala Nozari ORCID

Live enrichment

PubMed:33223037 OpenAlex:https://openalex.org/W3102410312

U.S. Air Force

Grant: FA8655-05-1-3065

Euskal Herriko Unibertsitatea

Grant: 14/08

National Institutes of Health

Grant: R01 AG028679

Eusko Jaurlaritza

Grant: CS-2203

Alzheimer's Association

Grant: IIRG-09-132087

FWCI

5.14

Citation Percentile

1.0%

Citation Trend

2021

2023

2024

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0079612320301631?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0079612320301631?httpAccept=text/plain

book serieshttps://doi.org/10.1016/bs.pbr.2020.09.004

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33223037

Fields of Study

Neurological Disorders and TreatmentsTraumatic Brain Injury and Neurovascular DisturbancesHeme Oxygenase-1 and Carbon MonoxideMedicineEnvironmental ScienceChemistryAmino AcidsBrainBrain InjuriesDiabetes MellitusHumansNanomedicineNeuroprotective AgentsPharmaceutical Preparations

MeSH Terms

Amino AcidsBrainBrain InjuriesDiabetes MellitusPharmaceutical PreparationsHumansNeuroprotective AgentsNanomedicine

Keywords

CerebrolysinMedicineNeuroprotectionNeuroscienceTraumatic brain injuryDiabetes mellitusPathophysiologyBioinformaticsPathologyInternal medicinePsychologyPsychiatryEndocrinologyBrain PathologyBlast Brain InjuryH-290/51 Nanomedicine

Sustainable Development Goals

SDG 0: Good health and well-being

REMOVED: Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine

FAIR Checklist

Authors (12)

Funding (5 grants)

Impact

Open Access

Topics